Timber Pharmaceuticals

-$0.0029 (-1.12%) As of 4:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TMBR and other ETFs, options, and stocks.

About TMBR

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma.

CEO
John Koconis
Employees
3
Headquarters
Basking Ridge, New Jersey
Founded
2019

TMBR Key Statistics

Market cap
16.27M
Price-Earnings ratio
—
Dividend yield
—
Average volume
323.04K
High today
$0.2593
Low today
$0.2455
Open price
$0.2593
Volume
111.14K
52 Week high
$1.41
52 Week low
$0.2306

TMBR Earnings

-$0.08
$0.06
$0.21
$0.35
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.05 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure